Absci Corp reports results for the quarter ended June 30 - Earnings Summary

Absci Corp reports results for the quarter ended June 30 - Earnings Summary
  • Absci Corp ABSI.OQ reported a quarterly adjusted loss of 21 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -24 cents. The mean expectation of ten analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -22 cents to -18 cents per share.

  • Revenue fell 46.4% to $318.00 thousand from a year ago; analysts expected $1.17 million.

  • Absci Corp's reported EPS for the quarter was a loss of 21 cents​.

  • The company reported a quarterly loss of $33.21 million.

  • Absci Corp shares had fallen by 22.3% this quarter and gained 158.2% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 5.5% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

  • Wall Street's median 12-month price target for Absci Corp is $14.00, about 35.6% above its last closing price of $9.01

This summary was machine generated from LSEG data August 11 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

-0.20

-0.21

Missed

Mar. 31 2026

-0.21

-0.19

Beat

Dec. 31 2025

-0.19

-0.20

Missed

Sep. 30 2025

-0.21

-0.20

Beat

Recent news on AbSci

See all news